Artikler med mandater om offentlig tilgang - Charles COUTANTLes mer
Ikke tilgjengelige noe sted: 2
Differentiation of groups of patients with cognitive complaints at breast cancer diagnosis: Results from a sub‐study of the French CANTO cohort
I Hardy‐Leger, C Charles, M Lange, F Joly, P Roux, A Capel, J Petrucci, ...
Psycho‐Oncology 30 (4), 463-470, 2021
Mandater: Agence Nationale de la Recherche
Change in the value of work after breast cancer: evidence from a prospective cohort
E Caumette, A Di Meglio, I Vaz-Luis, C Charles, J Havas, GR De Azua, ...
Journal of Cancer Survivorship 17 (3), 694-705, 2023
Mandater: Susan G. Komen
Tilgjengelige et eller annet sted: 39
Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer
SM Swain, J Baselga, SB Kim, J Ro, V Semiglazov, M Campone, ...
New England journal of medicine 372 (8), 724-734, 2015
Mandater: US National Institutes of Health
70-gene signature as an aid to treatment decisions in early-stage breast cancer
F Cardoso, LJ van’t Veer, J Bogaerts, L Slaets, G Viale, S Delaloge, ...
New England Journal of Medicine 375 (8), 717-729, 2016
Mandater: US National Institutes of Health, Cancer Research UK, Dutch Cancer Society …
Prospective validation of a 21-gene expression assay in breast cancer
JA Sparano, RJ Gray, DF Makower, KI Pritchard, KS Albain, DF Hayes, ...
New England Journal of Medicine 373 (21), 2005-2014, 2015
Mandater: US National Institutes of Health, Canadian Cancer Society, Susan G. Komen
Breast-cancer adjuvant therapy with zoledronic acid
RE Coleman, H Marshall, D Cameron, D Dodwell, R Burkinshaw, ...
New England Journal of Medicine 365 (15), 1396-1405, 2011
Mandater: Cancer Research UK
Effect of occult metastases on survival in node-negative breast cancer
DL Weaver, T Ashikaga, DN Krag, JM Skelly, SJ Anderson, SP Harlow, ...
New England Journal of Medicine 364 (5), 412-421, 2011
Mandater: US National Institutes of Health
In situ immune response after neoadjuvant chemotherapy for breast cancer predicts survival
S Ladoire, G Mignot, S Dabakuyo, L Arnould, L Apetoh, C Rébé, ...
The Journal of pathology 224 (3), 389-400, 2011
Mandater: National Institute of Health and Medical Research, France
Evaluation of a 30-gene paclitaxel, fluorouracil, doxorubicin, and cyclophosphamide chemotherapy response predictor in a multicenter randomized trial in breast cancer
A Tabchy, V Valero, T Vidaurre, A Lluch, H Gomez, M Martin, Y Qi, ...
Clinical Cancer Research 16 (21), 5351-5361, 2010
Mandater: US National Institutes of Health
Differential impact of endocrine therapy and chemotherapy on quality of life of breast cancer survivors: a prospective patient-reported outcomes analysis
AR Ferreira, A Di Meglio, B Pistilli, AS Gbenou, M El-Mouhebb, S Dauchy, ...
Annals of Oncology 30 (11), 1784-1795, 2019
Mandater: Agence Nationale de la Recherche, Susan G. Komen
Serum detection of nonadherence to adjuvant tamoxifen and breast cancer recurrence risk
B Pistilli, A Paci, AR Ferreira, A Di Meglio, V Poinsignon, A Bardet, ...
Journal of Clinical Oncology 38 (24), 2762-2772, 2020
Mandater: Susan G. Komen
Impact of breast cancer treatment on employment: results of a multicenter prospective cohort study (CANTO)
A Dumas, I Vaz Luis, T Bovagnet, M El Mouhebb, A Di Meglio, S Pinto, ...
Journal of Clinical Oncology 38 (7), 734-743, 2020
Mandater: Susan G. Komen
Monitoring HSP70 exosomes in cancer patients’ follow up: A clinical prospective pilot study
G Chanteloup, M Cordonnier, N Isambert, A Bertaut, A Hervieu, ...
Journal of extracellular vesicles 9 (1), 1766192, 2020
Mandater: Agence Nationale de la Recherche
Prospective comparison of clinical and genomic multivariate predictors of response to neoadjuvant chemotherapy in breast cancer
JK Lee, C Coutant, YC Kim, Y Qi, D Theodorescu, WF Symmans, ...
Clinical Cancer Research 16 (2), 711-718, 2010
Mandater: US National Institutes of Health
Clinical benefit from neoadjuvant chemotherapy in oestrogen receptor-positive invasive ductal and lobular carcinomas
Y Delpech, C Coutant, L Hsu, E Barranger, T Iwamoto, CH Barcenas, ...
British journal of cancer 108 (2), 285-291, 2013
Mandater: US National Institutes of Health
Delayed care for patients with newly diagnosed cancer due to COVID-19 and estimated impact on cancer mortality in France
JY Blay, S Boucher, B Le Vu, C Cropet, S Chabaud, D Perol, E Barranger, ...
ESMO open 6 (3), 100134, 2021
Mandater: National Institute of Health and Medical Research, France, Agence Nationale …
Association of body mass index and cardiotoxicity related to anthracyclines and trastuzumab in early breast cancer: French CANTO cohort study
EG Kaboré, C Guenancia, I Vaz-Luis, A Di Meglio, B Pistilli, C Coutant, ...
PLoS medicine 16 (12), e1002989, 2019
Mandater: Agence Nationale de la Recherche
Dynamics of long-term patient-reported quality of life and health behaviors after adjuvant breast cancer chemotherapy
A Di Meglio, J Havas, AS Gbenou, E Martin, M El-Mouhebb, B Pistilli, ...
Journal of Clinical Oncology 40 (27), 3190-3204, 2022
Mandater: US National Institutes of Health, Agence Nationale de la Recherche, Susan G …
Development and validation of a predictive model of severe fatigue after breast cancer diagnosis: toward a personalized framework in survivorship care
A Di Meglio, J Havas, D Soldato, D Presti, E Martin, B Pistilli, G Menvielle, ...
Journal of Clinical Oncology 40 (10), 1111-1123, 2022
Mandater: Agence Nationale de la Recherche, Susan G. Komen
Long-term longitudinal patterns of patient-reported fatigue after breast cancer: a group-based trajectory analysis
I Vaz-Luis, A Di Meglio, J Havas, M El-Mouhebb, P Lapidari, D Presti, ...
Journal of Clinical Oncology 40 (19), 2148-2162, 2022
Mandater: Agence Nationale de la Recherche, Susan G. Komen
Informasjon om publisering og finansiering fastsettes automatisk av et datamaskinprogram